{"gene":"CYTL1","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2007,"finding":"CYTL1 (Cytokine-like 1) promotes chondrogenic differentiation of mouse limb bud mesenchymal cells by stimulating Sox9 transcriptional activity and inducing IGF-1 expression, acting as an autocrine factor; exogenous CYTL1 or lentivirus-mediated overexpression caused chondrogenic differentiation in micromass culture, but CYTL1 did not affect hypertrophic maturation of chondrocytes.","method":"Exogenous protein treatment of mesenchymal micromass cultures, lentivirus-mediated overexpression, in vitro and in vivo expression profiling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (exogenous protein, overexpression, Sox9 activity assay) in a single study with clear functional readout","pmids":["17644814"],"is_preprint":false},{"year":2011,"finding":"Cytl1 knockout mice show normal cartilage and bone development but exhibit augmented osteoarthritic cartilage destruction upon destabilization of the medial meniscus, indicating that Cytl1 is required for cartilage homeostasis maintenance rather than development.","method":"Cytl1 knockout mouse generation; destabilization of medial meniscus OA model; histological analysis of cartilage","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined phenotypic readout replicated across both in vivo OA model and human OA tissue","pmids":["21652695"],"is_preprint":false},{"year":2011,"finding":"Computational structural modeling suggests CYTL1 adopts an IL8-like chemokine fold (similar to CCL2/MCP-1) rather than a 4-helical cytokine fold, and structure-based analysis identifies features in CYTL1 necessary for signaling through the CCR2 chemokine receptor.","method":"Molecular modeling, structure-based functional analysis","journal":"Proteins","confidence":"Low","confidence_rationale":"Tier 4 — computational prediction only, no experimental validation of the proposed CCR2 interaction or fold","pmids":["21322034"],"is_preprint":false},{"year":2011,"finding":"Systemic expression of C17 (CYTL1) in vivo reduces disease in a collagen antibody-induced arthritis mouse model, with reduced RANKL levels in paws and sera, bone protection, and blunted expression of genes associated with acute joint inflammation and cartilage/bone erosion.","method":"In vivo systemic overexpression in CAIA mouse model; histological analysis; gene expression profiling; RANKL measurement","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — clean in vivo gain-of-function with multiple readouts from a single lab","pmids":["21799806"],"is_preprint":false},{"year":2019,"finding":"CYTL1 inhibits tumor cell migration and invasion and decreases STAT3 phosphorylation in lung and breast cancer cells; in vivo, CYTL1 significantly inhibited tumor metastasis in breast cancer mouse models.","method":"Recombinant CYTL1 treatment; CYTL1-overexpressing tumor cell lines; migration/invasion assays; Western blot for STAT3 phosphorylation; experimental and spontaneous metastasis mouse models","journal":"Oncoimmunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal in vitro and in vivo methods from single lab","pmids":["31069137"],"is_preprint":false},{"year":2022,"finding":"Intracellular CYTL1 (lacking the 1-22 aa signal peptide, ΔCYTL1) competitively binds the N-terminal sequence of NDUFV1 to block MDM2-mediated proteasomal degradation, thereby stabilizing NDUFV1, which in turn increases NAD+ levels and interacts with Src to attenuate LDHA phosphorylation at tyrosine 10, reducing lactate production and reversing metabolic reprogramming (Warburg effect) in breast cancer cells.","method":"Co-immunoprecipitation; competitive binding assay; site-directed constructs (ΔCYTL1); proteasome inhibition experiments; LDHA Y10 phosphorylation assay; in vitro and in vivo tumor growth/metastasis models","journal":"Signal transduction and targeted therapy","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical and cellular assays identifying a specific binding interaction, PTM mechanism, and metabolic consequence with in vivo validation","pmids":["35115484"],"is_preprint":false},{"year":2016,"finding":"Cytl1 expression in mouse endometrium increases significantly during embryo implantation, and Cytl1 enhances endometrial cell proliferation, stimulates secretion of LIF and HB-EGF, and enhances adhesion of endometrial cells to JAR spheroids, suggesting a role in embryo implantation.","method":"In vivo mouse expression profiling; cell proliferation assays; ELISA for LIF and HB-EGF; cell-cell adhesion assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 — multiple functional readouts but single lab, no receptor/pathway mechanism established","pmids":["26800213"],"is_preprint":false},{"year":2019,"finding":"CYTL1 was identified as a secreted protein whose chondrogenic activity involves modulation of Sox9 and IGF-1 expression, and CCR2 has been identified as a likely receptor mediating the ERK signalling pathway; CYTL1 also appears to mediate TGF-beta-Smad signalling independently of CCR2.","method":"Review/synthesis of prior experimental data (not primary experimental data in this paper)","journal":"Cellular and molecular life sciences : CMLS","confidence":"Low","confidence_rationale":"Tier 3 — review article synthesizing prior findings; CCR2/ERK and TGF-beta/Smad pathway links not directly demonstrated in primary experiments within this paper","pmids":["31089746"],"is_preprint":false}],"current_model":"CYTL1 (Cytokine-like 1/Protein C17) is a secreted cytokine-like protein that promotes chondrogenesis by stimulating Sox9 transcriptional activity and IGF-1 expression, maintains cartilage homeostasis (loss exacerbates osteoarthritis), inhibits tumor metastasis by reducing STAT3 phosphorylation, and in its intracellular signal-peptide-deleted form (ΔCYTL1) acts as a tumor suppressor by competitively binding NDUFV1 to block MDM2-mediated proteasomal degradation, thereby stabilizing NDUFV1, increasing NAD+ levels, and attenuating LDHA Y10 phosphorylation to suppress aerobic glycolysis in breast cancer."},"narrative":{"teleology":[{"year":2007,"claim":"Establishing CYTL1 as a chondrogenic factor resolved its biological activity: it promotes mesenchymal chondrogenesis through Sox9 activation and IGF-1 induction, functioning as an autocrine differentiation signal rather than a classical immune cytokine.","evidence":"Exogenous recombinant CYTL1 and lentiviral overexpression in mouse limb bud mesenchymal micromass cultures with Sox9 activity assays and expression profiling","pmids":["17644814"],"confidence":"High","gaps":["The receptor mediating CYTL1's chondrogenic signal was not identified","Downstream signaling cascades beyond Sox9 and IGF-1 were not mapped","In vivo requirement for CYTL1 in skeletal development was untested"]},{"year":2011,"claim":"Genetic ablation revealed that CYTL1 is dispensable for cartilage development but essential for cartilage homeostasis under pathological stress, shifting the functional model from a developmental factor to a maintenance/protective factor.","evidence":"Cytl1 knockout mice subjected to destabilization of the medial meniscus OA model with histological analysis","pmids":["21652695"],"confidence":"High","gaps":["The molecular mechanism by which CYTL1 protects against cartilage destruction was not defined","Whether CYTL1 signals through a specific receptor in chondrocytes in vivo was unresolved"]},{"year":2011,"claim":"Systemic CYTL1 overexpression demonstrated an anti-inflammatory and bone-protective role in arthritis, broadening its function beyond chondrogenesis to include suppression of RANKL and joint inflammation.","evidence":"In vivo systemic overexpression in collagen antibody-induced arthritis mouse model with histology, gene expression profiling, and RANKL measurement","pmids":["21799806"],"confidence":"Medium","gaps":["The direct cellular targets of CYTL1 in the inflammatory joint were not identified","The signaling pathway through which CYTL1 suppresses RANKL was not determined"]},{"year":2016,"claim":"Discovery of CYTL1 upregulation during embryo implantation and its ability to stimulate endometrial cell proliferation and adhesion extended its functional repertoire to reproductive biology.","evidence":"In vivo mouse endometrial expression profiling, cell proliferation assays, ELISA for LIF/HB-EGF, and JAR spheroid adhesion assays","pmids":["26800213"],"confidence":"Medium","gaps":["The receptor and signaling pathway mediating endometrial effects were not identified","Genetic loss-of-function in the implantation context was not tested","Whether CYTL1's endometrial role is required in vivo for fertility is unknown"]},{"year":2019,"claim":"Demonstrating that secreted CYTL1 inhibits tumor metastasis and reduces STAT3 phosphorylation established a tumor-suppressive extracellular signaling axis distinct from its chondrogenic function.","evidence":"Recombinant CYTL1 treatment and overexpression in lung and breast cancer cell lines; migration/invasion assays; Western blot for pSTAT3; experimental and spontaneous metastasis mouse models","pmids":["31069137"],"confidence":"Medium","gaps":["The receptor through which CYTL1 suppresses STAT3 in cancer cells was not identified","Whether STAT3 inhibition is direct or mediated through an intermediate kinase was not resolved"]},{"year":2022,"claim":"Identification of the intracellular signal-peptide-deleted form (ΔCYTL1) as a competitive inhibitor of MDM2-mediated NDUFV1 degradation revealed a cell-autonomous tumor-suppressive mechanism that stabilizes NDUFV1, increases NAD⁺, and suppresses LDHA-driven aerobic glycolysis.","evidence":"Co-immunoprecipitation, competitive binding assays, site-directed ΔCYTL1 constructs, proteasome inhibition, LDHA Y10 phosphorylation assays, and in vivo tumor growth/metastasis models in breast cancer","pmids":["35115484"],"confidence":"High","gaps":["The relative physiological abundance of the intracellular ΔCYTL1 form versus the secreted form in normal tissues is undefined","Whether ΔCYTL1 generation is regulated or constitutive is unknown","Independent replication of the NDUFV1 stabilization mechanism in other cancer types has not been reported"]},{"year":null,"claim":"The identity of the cell-surface receptor for secreted CYTL1 remains unresolved: CCR2 has been computationally proposed but not experimentally validated, and the signaling cascades linking receptor engagement to Sox9 activation, STAT3 suppression, and cartilage protection are not defined.","evidence":"","pmids":[],"confidence":"Low","gaps":["No receptor has been experimentally confirmed for secreted CYTL1","The relationship between extracellular and intracellular CYTL1 functions is mechanistically unconnected","Structural determination of CYTL1 protein has not been performed experimentally"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,3,4]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,5]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5]}],"complexes":[],"partners":["NDUFV1","MDM2","LDHA","SOX9"],"other_free_text":[]},"mechanistic_narrative":"CYTL1 is a secreted cytokine-like protein that functions as an autocrine/paracrine factor in chondrogenesis and cartilage homeostasis, and additionally acts as a tumor suppressor through both extracellular and intracellular mechanisms. As a secreted factor, CYTL1 promotes chondrogenic differentiation of mesenchymal cells by stimulating Sox9 transcriptional activity and inducing IGF-1 expression, and its genetic ablation in mice augments osteoarthritic cartilage destruction without affecting skeletal development [PMID:17644814, PMID:21652695]. Extracellular CYTL1 inhibits tumor metastasis and reduces STAT3 phosphorylation in cancer cells [PMID:31069137], while the intracellular signal-peptide-deleted form (ΔCYTL1) competitively binds NDUFV1 to block MDM2-mediated proteasomal degradation, stabilizing NDUFV1 and thereby increasing NAD⁺ levels and attenuating LDHA Y10 phosphorylation to suppress aerobic glycolysis in breast cancer [PMID:35115484]. Systemic CYTL1 expression also protects against inflammatory arthritis in vivo by reducing RANKL levels and blunting joint inflammation [PMID:21799806]."},"prefetch_data":{"uniprot":{"accession":"Q9NRR1","full_name":"Cytokine-like protein 1","aliases":["Protein C17"],"length_aa":136,"mass_kda":15.6,"function":"","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q9NRR1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CYTL1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CYTL1","total_profiled":1310},"omim":[{"mim_id":"607930","title":"CYTOKINE-LIKE PROTEIN 1; CYTL1","url":"https://www.omim.org/entry/607930"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear membrane","reliability":"Approved"},{"location":"Endoplasmic reticulum","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":198.0}],"url":"https://www.proteinatlas.org/search/CYTL1"},"hgnc":{"alias_symbol":["C17","C4orf4"],"prev_symbol":[]},"alphafold":{"accession":"Q9NRR1","domains":[{"cath_id":"-","chopping":"26-115","consensus_level":"high","plddt":92.9166,"start":26,"end":115}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NRR1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NRR1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NRR1-F1-predicted_aligned_error_v6.png","plddt_mean":85.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CYTL1","jax_strain_url":"https://www.jax.org/strain/search?query=CYTL1"},"sequence":{"accession":"Q9NRR1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NRR1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NRR1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NRR1"}},"corpus_meta":[{"pmid":"6971291","id":"PMC_6971291","title":"Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase).","date":"1981","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6971291","citation_count":282,"is_preprint":false},{"pmid":"6793062","id":"PMC_6793062","title":"Microsomal cytochrome P-450 from neonatal pig testis: two enzymatic activities (17 alpha-hydroxylase and c17,20-lyase) associated with one protein.","date":"1981","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6793062","citation_count":265,"is_preprint":false},{"pmid":"7918112","id":"PMC_7918112","title":"Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase).","date":"1994","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7918112","citation_count":217,"is_preprint":false},{"pmid":"6608525","id":"PMC_6608525","title":"C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17 alpha-hydroxylase/C17,20-lyase cytochrome P-450.","date":"1984","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6608525","citation_count":200,"is_preprint":false},{"pmid":"8825555","id":"PMC_8825555","title":"The orphan nuclear receptor steroidogenic factor-1 regulates the cyclic adenosine 3',5'-monophosphate-mediated transcriptional activation of rat cytochrome P450c17 (17 alpha-hydroxylase/c17-20 lyase).","date":"1996","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8825555","citation_count":163,"is_preprint":false},{"pmid":"8013361","id":"PMC_8013361","title":"Ontogeny of expression of the genes for steroidogenic enzymes P450 side-chain cleavage, 3 beta-hydroxysteroid dehydrogenase, P450 17 alpha-hydroxylase/C17-20 lyase, and P450 aromatase in fetal mouse gonads.","date":"1994","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8013361","citation_count":159,"is_preprint":false},{"pmid":"1425417","id":"PMC_1425417","title":"Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 expression.","date":"1992","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1425417","citation_count":141,"is_preprint":false},{"pmid":"1874181","id":"PMC_1874181","title":"Multiple mechanisms for regulation of 3 beta-hydroxysteroid dehydrogenase/delta 5----delta 4-isomerase, 17 alpha-hydroxylase/C17-20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells.","date":"1991","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1874181","citation_count":130,"is_preprint":false},{"pmid":"24276076","id":"PMC_24276076","title":"CYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents.","date":"2013","source":"Nature reviews. Urology","url":"https://pubmed.ncbi.nlm.nih.gov/24276076","citation_count":126,"is_preprint":false},{"pmid":"2160293","id":"PMC_2160293","title":"Hormonal regulation of cytochrome P450 enzymes, cholesterol side-chain cleavage and 17 alpha-hydroxylase/C17-20 lyase in Leydig cells.","date":"1990","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/2160293","citation_count":120,"is_preprint":false},{"pmid":"8603575","id":"PMC_8603575","title":"Expression of cytochrome P450 17alpha-hydroxylase/C17-20 lyase in the fetal rat testis is reduced by maternal exposure to exogenous estrogens.","date":"1996","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8603575","citation_count":119,"is_preprint":false},{"pmid":"20193781","id":"PMC_20193781","title":"Synergistic effects of electrospun PLLA fiber dimension and pattern on neonatal mouse cerebellum C17.2 stem cells.","date":"2010","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/20193781","citation_count":91,"is_preprint":false},{"pmid":"12767280","id":"PMC_12767280","title":"Effects of novel 17alpha-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo.","date":"2003","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12767280","citation_count":84,"is_preprint":false},{"pmid":"9379450","id":"PMC_9379450","title":"17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha).","date":"1997","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9379450","citation_count":84,"is_preprint":false},{"pmid":"2856411","id":"PMC_2856411","title":"Noncoordinate regulation of de novo synthesis of cytochrome P-450 cholesterol side-chain cleavage and cytochrome P-450 17 alpha-hydroxylase/C17-20 lyase in mouse Leydig cell cultures: relation to steroid production.","date":"1987","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/2856411","citation_count":80,"is_preprint":false},{"pmid":"16544941","id":"PMC_16544941","title":"Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications.","date":"2006","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/16544941","citation_count":77,"is_preprint":false},{"pmid":"1487710","id":"PMC_1487710","title":"Immunohistochemical localization of 17 alpha-hydroxylase/C17-20 lyase and aromatase cytochrome P-450 in the human ovary during the menstrual cycle.","date":"1992","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1487710","citation_count":72,"is_preprint":false},{"pmid":"9882543","id":"PMC_9882543","title":"Androgen synthesis in a songbird: a study of cyp17 (17alpha-hydroxylase/C17,20-lyase) activity in the zebra finch.","date":"1999","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9882543","citation_count":66,"is_preprint":false},{"pmid":"17644814","id":"PMC_17644814","title":"Cytokine-like 1 (Cytl1) regulates the chondrogenesis of mesenchymal cells.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17644814","citation_count":64,"is_preprint":false},{"pmid":"1270966","id":"PMC_1270966","title":"Activity of steroid C-17,20 lyase in the ovine placenta: effect of exposure to foetal glucocorticoid.","date":"1976","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/1270966","citation_count":64,"is_preprint":false},{"pmid":"11311872","id":"PMC_11311872","title":"Expression and localization of cytochrome P450 17 alpha-hydroxylase/c17,20-lyase in the avian brain.","date":"2001","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11311872","citation_count":63,"is_preprint":false},{"pmid":"6705734","id":"PMC_6705734","title":"The interaction of C-17 esters of estradiol with the estrogen receptor.","date":"1984","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/6705734","citation_count":57,"is_preprint":false},{"pmid":"7628389","id":"PMC_7628389","title":"Tumor necrosis factor-alpha inhibition of 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) expression.","date":"1995","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/7628389","citation_count":50,"is_preprint":false},{"pmid":"21652695","id":"PMC_21652695","title":"Cytokine-like 1 knock-out mice (Cytl1-/-) show normal cartilage and bone development but exhibit augmented osteoarthritic cartilage destruction.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21652695","citation_count":47,"is_preprint":false},{"pmid":"18260615","id":"PMC_18260615","title":"Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents.","date":"2008","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18260615","citation_count":47,"is_preprint":false},{"pmid":"11087568","id":"PMC_11087568","title":"Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17).","date":"2000","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11087568","citation_count":44,"is_preprint":false},{"pmid":"1840559","id":"PMC_1840559","title":"Isolation, characterization, and chromosomal mapping of mouse P450 17 alpha-hydroxylase/C17-20 lyase.","date":"1991","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1840559","citation_count":43,"is_preprint":false},{"pmid":"10896104","id":"PMC_10896104","title":"Novel imidazolyl and triazolyl substituted biphenyl compounds: synthesis and evaluation as nonsteroidal inhibitors of human 17alpha-hydroxylase-C17, 20-lyase (P450 17).","date":"2000","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10896104","citation_count":43,"is_preprint":false},{"pmid":"27618740","id":"PMC_27618740","title":"Selective and differential interactions of BNN27, a novel C17-spiroepoxy steroid derivative, with TrkA receptors, regulating neuronal survival and differentiation.","date":"2016","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27618740","citation_count":39,"is_preprint":false},{"pmid":"8863811","id":"PMC_8863811","title":"Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17 alpha-hydroxylase/C17,20-lyase.","date":"1996","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8863811","citation_count":39,"is_preprint":false},{"pmid":"32486470","id":"PMC_32486470","title":"Bioactive C17 and C18 Acetylenic Oxylipins from Terrestrial Plants as Potential Lead Compounds for Anticancer Drug Development.","date":"2020","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/32486470","citation_count":38,"is_preprint":false},{"pmid":"8994191","id":"PMC_8994191","title":"Repression of cAMP-induced expression of the mouse P450 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) by androgens.","date":"1997","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8994191","citation_count":37,"is_preprint":false},{"pmid":"21290546","id":"PMC_21290546","title":"Neuronal differentiation of C17.2 neural stem cells induced by a natural flavonoid, baicalin.","date":"2011","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/21290546","citation_count":37,"is_preprint":false},{"pmid":"8894102","id":"PMC_8894102","title":"20-amino and 20,21-aziridinyl pregnene steroids: development of potent inhibitors of 17 alpha-hydroxylase/C17,20-lyase (P450 17).","date":"1996","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8894102","citation_count":36,"is_preprint":false},{"pmid":"22542584","id":"PMC_22542584","title":"Optimisation of culture conditions for differentiation of C17.2 neural stem cells to be used for in vitro toxicity tests.","date":"2012","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/22542584","citation_count":36,"is_preprint":false},{"pmid":"25016955","id":"PMC_25016955","title":"Thermal stability of ginkgolic acids from Ginkgo biloba and the effects of ginkgol C17:1 on the apoptosis and migration of SMMC7721 cells.","date":"2014","source":"Fitoterapia","url":"https://pubmed.ncbi.nlm.nih.gov/25016955","citation_count":36,"is_preprint":false},{"pmid":"12517438","id":"PMC_12517438","title":"Synthesis of 21,21-difluoro-3 beta-hydroxy-20-methylpregna-5,20-diene and 5,16,20-triene as potential inhibitors of steroid C17(20) lyase.","date":"2003","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12517438","citation_count":36,"is_preprint":false},{"pmid":"21530693","id":"PMC_21530693","title":"Electroconductive polymeric nanowire templates facilitates in vitro C17.2 neural stem cell line adhesion, proliferation and differentiation.","date":"2011","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/21530693","citation_count":34,"is_preprint":false},{"pmid":"9689499","id":"PMC_9689499","title":"C16 and C17 derivatives of estradiol as inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1: chemical synthesis and structure-activity relationships.","date":"1998","source":"Drug design and discovery","url":"https://pubmed.ncbi.nlm.nih.gov/9689499","citation_count":34,"is_preprint":false},{"pmid":"16963309","id":"PMC_16963309","title":"Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.","date":"2006","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/16963309","citation_count":33,"is_preprint":false},{"pmid":"18355883","id":"PMC_18355883","title":"17-Hydroxylase/C17,20-lyase (CYP17) is not the enzyme responsible for side-chain cleavage of cortisol and its metabolites.","date":"2008","source":"Steroids","url":"https://pubmed.ncbi.nlm.nih.gov/18355883","citation_count":33,"is_preprint":false},{"pmid":"12736515","id":"PMC_12736515","title":"Studies on the interactions between drug and estrogen. II. On the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17.","date":"2003","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/12736515","citation_count":33,"is_preprint":false},{"pmid":"2303257","id":"PMC_2303257","title":"No evidence for linkage between late onset autosomal dominant retinitis pigmentosa and chromosome 3 locus D3S47 (C17): evidence for genetic heterogeneity.","date":"1990","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/2303257","citation_count":32,"is_preprint":false},{"pmid":"15080924","id":"PMC_15080924","title":"C17,20-lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitors.","date":"2004","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15080924","citation_count":31,"is_preprint":false},{"pmid":"28485924","id":"PMC_28485924","title":"Cooperative Interactions in the Hammerhead Ribozyme Drive pKa Shifting of G12 and Its Stacked Base C17.","date":"2017","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28485924","citation_count":31,"is_preprint":false},{"pmid":"17954250","id":"PMC_17954250","title":"Combination of C(17) sphingoid base homologues and mass spectrometry analysis as a new approach to study sphingolipid metabolism.","date":"2007","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/17954250","citation_count":31,"is_preprint":false},{"pmid":"1606043","id":"PMC_1606043","title":"4-pregnene-3-one-20 beta-carboxaldehyde: a potent inhibitor of 17 alpha-hydroxylase/C17,20-lyase and of 5 alpha-reductase.","date":"1992","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1606043","citation_count":29,"is_preprint":false},{"pmid":"19500725","id":"PMC_19500725","title":"A role for cytochrome P450 17alpha-hydroxylase/c17-20 lyase during shift in steroidogenesis occurring in ovarian follicles prior to oocyte maturation.","date":"2009","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19500725","citation_count":28,"is_preprint":false},{"pmid":"1547314","id":"PMC_1547314","title":"Cellular localization and factors controlling rat placental cytochrome P45017 alpha (CYP17): 17 alpha-hydroxylase/C17,20-lyase activity.","date":"1992","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/1547314","citation_count":27,"is_preprint":false},{"pmid":"31089746","id":"PMC_31089746","title":"Protein Cytl1: its role in chondrogenesis, cartilage homeostasis, and disease.","date":"2019","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/31089746","citation_count":26,"is_preprint":false},{"pmid":"26368264","id":"PMC_26368264","title":"Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.","date":"2015","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26368264","citation_count":26,"is_preprint":false},{"pmid":"35115484","id":"PMC_35115484","title":"Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer.","date":"2022","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35115484","citation_count":24,"is_preprint":false},{"pmid":"23782242","id":"PMC_23782242","title":"Temperature and respiration affect the growth and stress resistance of Lactobacillus plantarum C17.","date":"2013","source":"Journal of applied microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/23782242","citation_count":24,"is_preprint":false},{"pmid":"26828720","id":"PMC_26828720","title":"Ionizing Radiation Induces Altered Neuronal Differentiation by mGluR1 through PI3K-STAT3 Signaling in C17.2 Mouse Neural Stem-Like Cells.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26828720","citation_count":24,"is_preprint":false},{"pmid":"10940197","id":"PMC_10940197","title":"Temporal expression of prostaglandin H synthase type 2 (PGHS-2) and P450(C17)in ovine placentomes with the natural onset of labour.","date":"2000","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/10940197","citation_count":24,"is_preprint":false},{"pmid":"2393026","id":"PMC_2393026","title":"Linkage to D3S47 (C17) in one large autosomal dominant retinitis pigmentosa family and exclusion in another: confirmation of genetic heterogeneity.","date":"1990","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2393026","citation_count":24,"is_preprint":false},{"pmid":"25649541","id":"PMC_25649541","title":"Toxoplasma gondii prevalent in China induce weaker apoptosis of neural stem cells C17.2 via endoplasmic reticulum stress (ERS) signaling pathways.","date":"2015","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/25649541","citation_count":24,"is_preprint":false},{"pmid":"10036137","id":"PMC_10036137","title":"Cytochrome P450c17-expressing Escherichia coli as a first-step screening system for 17alpha-hydroxylase-C17,20-lyase inhibitors.","date":"1999","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10036137","citation_count":24,"is_preprint":false},{"pmid":"31551713","id":"PMC_31551713","title":"Berberine Protects C17.2 Neural Stem Cells From Oxidative Damage Followed by Inducing Neuronal Differentiation.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31551713","citation_count":22,"is_preprint":false},{"pmid":"20595043","id":"PMC_20595043","title":"Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20595043","citation_count":22,"is_preprint":false},{"pmid":"8836168","id":"PMC_8836168","title":"Microbial transformations of steroids--X. Cytochromes P-450 11 alpha-hydroxylase and C17-C20 lyase and a 1-ene dehydrogenase transform steroids in Nectria haematococca.","date":"1996","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8836168","citation_count":21,"is_preprint":false},{"pmid":"34505136","id":"PMC_34505136","title":"CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3.","date":"2022","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34505136","citation_count":20,"is_preprint":false},{"pmid":"31069137","id":"PMC_31069137","title":"CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation.","date":"2019","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/31069137","citation_count":20,"is_preprint":false},{"pmid":"27209562","id":"PMC_27209562","title":"Synthesis of novel 17-(4'-formyl)pyrazolylandrosta-5,16-dienes and their derivatives as potent 17α-hydroxylase/C17,20-lyase inhibitors or antiproliferative agents depending on the substitution pattern of the heteroring.","date":"2016","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27209562","citation_count":20,"is_preprint":false},{"pmid":"27018151","id":"PMC_27018151","title":"Perfluorooctane sulfonate (PFOS) impairs the proliferation of C17.2 neural stem cells via the downregulation of GSK-3β/β-catenin signaling.","date":"2016","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/27018151","citation_count":20,"is_preprint":false},{"pmid":"24021891","id":"PMC_24021891","title":"Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives.","date":"2013","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24021891","citation_count":20,"is_preprint":false},{"pmid":"8828839","id":"PMC_8828839","title":"Regulation by gonadotropins of the messenger ribonucleic acid for P450 side-chain cleavage, P450(17) alpha-hydroxylase/C17,20-lyase, and 3 beta-hydroxysteroid dehydrogenase in cultured pig Leydig cells.","date":"1996","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/8828839","citation_count":20,"is_preprint":false},{"pmid":"25310508","id":"PMC_25310508","title":"Maintenance and neuronal cell differentiation of neural stem cells C17.2 correlated to medium availability sets design criteria in microfluidic systems.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25310508","citation_count":19,"is_preprint":false},{"pmid":"25912432","id":"PMC_25912432","title":"The downregulation of Wnt/β-catenin signaling pathway is associated with zinc deficiency-induced proliferative deficit of C17.2 neural stem cells.","date":"2015","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/25912432","citation_count":19,"is_preprint":false},{"pmid":"2139634","id":"PMC_2139634","title":"C17, a retrovirally immortalized neuronal cell line, inhibits the proliferation of astrocytes and astrocytoma cells by a contact-mediated mechanism.","date":"1990","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/2139634","citation_count":18,"is_preprint":false},{"pmid":"17468395","id":"PMC_17468395","title":"Inhibition of cytochrome P-450 C17 enzyme by a GnRH agonist in ovarian follicles from gonadotropin-stimulated rats.","date":"2007","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17468395","citation_count":18,"is_preprint":false},{"pmid":"25997481","id":"PMC_25997481","title":"Fasudil Stimulates Neurite Outgrowth and Promotes Differentiation in C17.2 Neural Stem Cells by Modulating Notch Signalling but not Autophagy.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25997481","citation_count":18,"is_preprint":false},{"pmid":"24140269","id":"PMC_24140269","title":"Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation.","date":"2013","source":"Psychoneuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24140269","citation_count":18,"is_preprint":false},{"pmid":"1329985","id":"PMC_1329985","title":"Cyclic AMP regulates expression of the rat gene for steroid 17 alpha-hydroxylase/C17-20 lyase P-450 (CYP17) in rat Leydig cells.","date":"1992","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/1329985","citation_count":18,"is_preprint":false},{"pmid":"8579376","id":"PMC_8579376","title":"Functional expression of recombinant spiny dogfish shark (Squalus acanthias) cytochrome P450c17 (17 alpha-hydroxylase/C17,20-lyase) in yeast (Pichia pastoris).","date":"1996","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/8579376","citation_count":18,"is_preprint":false},{"pmid":"24211641","id":"PMC_24211641","title":"An efficient approach to novel 17-5'-(1',2',4')-oxadiazolyl androstenes via the cyclodehydration of cytotoxic O-steroidacylamidoximes, and an evaluation of their inhibitory action on 17α-hydroxylase/C₁₇,₂₀-lyase.","date":"2013","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24211641","citation_count":18,"is_preprint":false},{"pmid":"2805166","id":"PMC_2805166","title":"Inhibitory effect and interaction of stanozolol with pig testicular cytochrome P-450 (17 alpha-hydroxylase/C17,20-lyase).","date":"1989","source":"Chemical & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/2805166","citation_count":18,"is_preprint":false},{"pmid":"3266718","id":"PMC_3266718","title":"A normal phase high-performance liquid chromatography system for steroid 17 alpha-hydroxylase/C17-20 lyase (cytochrome P-450 21scc) assays.","date":"1988","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3266718","citation_count":18,"is_preprint":false},{"pmid":"22613542","id":"PMC_22613542","title":"ANKRD7 and CYTL1 are novel risk genes for alcohol drinking behavior.","date":"2012","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22613542","citation_count":17,"is_preprint":false},{"pmid":"30563240","id":"PMC_30563240","title":"Mangrove Tirucallane- and Apotirucallane-Type Triterpenoids: Structure Diversity of the C-17 Side-Chain and Natural Agonists of Human Farnesoid/Pregnane⁻X⁻Receptor.","date":"2018","source":"Marine drugs","url":"https://pubmed.ncbi.nlm.nih.gov/30563240","citation_count":17,"is_preprint":false},{"pmid":"38547895","id":"PMC_38547895","title":"Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.","date":"2024","source":"The Lancet. Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38547895","citation_count":17,"is_preprint":false},{"pmid":"37130331","id":"PMC_37130331","title":"Design, Synthesis, and Bioevaluation of Novel MyD88 Inhibitor c17 against Acute Lung Injury Derived from the Virtual Screen.","date":"2023","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37130331","citation_count":17,"is_preprint":false},{"pmid":"22989379","id":"PMC_22989379","title":"Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.","date":"2012","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22989379","citation_count":17,"is_preprint":false},{"pmid":"16462589","id":"PMC_16462589","title":"Knockdown of Stat3 in C17.2 neural stem cells facilitates the generation of neurons: a possibility of transplantation with a low level of oncogene.","date":"2006","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/16462589","citation_count":17,"is_preprint":false},{"pmid":"17786622","id":"PMC_17786622","title":"Comparison of the 17 alpha-hydroxylase/C17,20-lyase activities of porcine, guinea pig and bovine P450c17 using purified recombinant fusion proteins containing P450c17 linked to NADPH-P450 reductase.","date":"2007","source":"Drug metabolism reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17786622","citation_count":17,"is_preprint":false},{"pmid":"2373976","id":"PMC_2373976","title":"The cytochrome P450(17) alpha (17 alpha-hydroxylase/C17,20-lyase) activity of the junctional zone of the rat placenta.","date":"1990","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/2373976","citation_count":17,"is_preprint":false},{"pmid":"1539595","id":"PMC_1539595","title":"Recombination between rhodopsin and locus D3S47 (C17) in rhodopsin retinitis pigmentosa families.","date":"1992","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1539595","citation_count":16,"is_preprint":false},{"pmid":"2559252","id":"PMC_2559252","title":"Inhibition of 17 alpha-hydroxylase/C17-C20 lyase by bifluranol and its analogues.","date":"1989","source":"Journal of steroid biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2559252","citation_count":16,"is_preprint":false},{"pmid":"21322034","id":"PMC_21322034","title":"Identification of CCR2-binding features in Cytl1 by a CCL2-like chemokine model.","date":"2011","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/21322034","citation_count":15,"is_preprint":false},{"pmid":"21799806","id":"PMC_21799806","title":"C17 prevents inflammatory arthritis and associated joint destruction in mice.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21799806","citation_count":15,"is_preprint":false},{"pmid":"12422273","id":"PMC_12422273","title":"Fluorescent probes DPH, TMA-DPH and C17-HC induce erythrocyte exovesiculation.","date":"2002","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/12422273","citation_count":15,"is_preprint":false},{"pmid":"375226","id":"PMC_375226","title":"Mutations reducing the activity of c17, a promoter of phage lambda formed by a tandem duplication.","date":"1979","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/375226","citation_count":15,"is_preprint":false},{"pmid":"12767278","id":"PMC_12767278","title":"In vitro and in vivo models for the evaluation of potent inhibitors of male rat 17alpha-hydroxylase/C17,20-lyase.","date":"2003","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12767278","citation_count":14,"is_preprint":false},{"pmid":"22943143","id":"PMC_22943143","title":"Basic fibroblast growth factor protects C17.2 cells from radiation-induced injury through ERK1/2.","date":"2012","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/22943143","citation_count":14,"is_preprint":false},{"pmid":"6610582","id":"PMC_6610582","title":"The in vitro and in vivo effect of estradiol upon the 17 alpha-hydroxylase and C17,20-lyase activity in the ovaries of immature hypophysectomized rats.","date":"1984","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/6610582","citation_count":14,"is_preprint":false},{"pmid":"8133216","id":"PMC_8133216","title":"Immunohistochemical localization of 17 alpha-hydroxylase/C17-20 lyase and aromatase cytochrome P-450 in polycystic human ovaries.","date":"1993","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8133216","citation_count":14,"is_preprint":false},{"pmid":"12444467","id":"PMC_12444467","title":"Seasonal changes in the activity of cytochrome P450(C17) from the testis of Bufo arenarum.","date":"2002","source":"Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12444467","citation_count":14,"is_preprint":false},{"pmid":"26800213","id":"PMC_26800213","title":"Cytokine-Like Protein 1(Cytl1): A Potential Molecular Mediator in Embryo Implantation.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26800213","citation_count":13,"is_preprint":false},{"pmid":"29169404","id":"PMC_29169404","title":"A mechanistic study of Toxoplasma gondii ROP18 inhibiting differentiation of C17.2 neural stem cells.","date":"2017","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/29169404","citation_count":13,"is_preprint":false},{"pmid":"30597876","id":"PMC_30597876","title":"Isolation and Absolute Configurations of Diversiform C17, C21 and C25 Terpenoids from the Marine Sponge Cacospongia sp.","date":"2018","source":"Marine drugs","url":"https://pubmed.ncbi.nlm.nih.gov/30597876","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53488,"output_tokens":1986,"usd":0.095127},"stage2":{"model":"claude-opus-4-6","input_tokens":5265,"output_tokens":2094,"usd":0.118013},"total_usd":0.21314,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"CYTL1 (Cytokine-like 1) promotes chondrogenic differentiation of mouse limb bud mesenchymal cells by stimulating Sox9 transcriptional activity and inducing IGF-1 expression, acting as an autocrine factor; exogenous CYTL1 or lentivirus-mediated overexpression caused chondrogenic differentiation in micromass culture, but CYTL1 did not affect hypertrophic maturation of chondrocytes.\",\n      \"method\": \"Exogenous protein treatment of mesenchymal micromass cultures, lentivirus-mediated overexpression, in vitro and in vivo expression profiling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (exogenous protein, overexpression, Sox9 activity assay) in a single study with clear functional readout\",\n      \"pmids\": [\"17644814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Cytl1 knockout mice show normal cartilage and bone development but exhibit augmented osteoarthritic cartilage destruction upon destabilization of the medial meniscus, indicating that Cytl1 is required for cartilage homeostasis maintenance rather than development.\",\n      \"method\": \"Cytl1 knockout mouse generation; destabilization of medial meniscus OA model; histological analysis of cartilage\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined phenotypic readout replicated across both in vivo OA model and human OA tissue\",\n      \"pmids\": [\"21652695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Computational structural modeling suggests CYTL1 adopts an IL8-like chemokine fold (similar to CCL2/MCP-1) rather than a 4-helical cytokine fold, and structure-based analysis identifies features in CYTL1 necessary for signaling through the CCR2 chemokine receptor.\",\n      \"method\": \"Molecular modeling, structure-based functional analysis\",\n      \"journal\": \"Proteins\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational prediction only, no experimental validation of the proposed CCR2 interaction or fold\",\n      \"pmids\": [\"21322034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Systemic expression of C17 (CYTL1) in vivo reduces disease in a collagen antibody-induced arthritis mouse model, with reduced RANKL levels in paws and sera, bone protection, and blunted expression of genes associated with acute joint inflammation and cartilage/bone erosion.\",\n      \"method\": \"In vivo systemic overexpression in CAIA mouse model; histological analysis; gene expression profiling; RANKL measurement\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean in vivo gain-of-function with multiple readouts from a single lab\",\n      \"pmids\": [\"21799806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CYTL1 inhibits tumor cell migration and invasion and decreases STAT3 phosphorylation in lung and breast cancer cells; in vivo, CYTL1 significantly inhibited tumor metastasis in breast cancer mouse models.\",\n      \"method\": \"Recombinant CYTL1 treatment; CYTL1-overexpressing tumor cell lines; migration/invasion assays; Western blot for STAT3 phosphorylation; experimental and spontaneous metastasis mouse models\",\n      \"journal\": \"Oncoimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro and in vivo methods from single lab\",\n      \"pmids\": [\"31069137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Intracellular CYTL1 (lacking the 1-22 aa signal peptide, ΔCYTL1) competitively binds the N-terminal sequence of NDUFV1 to block MDM2-mediated proteasomal degradation, thereby stabilizing NDUFV1, which in turn increases NAD+ levels and interacts with Src to attenuate LDHA phosphorylation at tyrosine 10, reducing lactate production and reversing metabolic reprogramming (Warburg effect) in breast cancer cells.\",\n      \"method\": \"Co-immunoprecipitation; competitive binding assay; site-directed constructs (ΔCYTL1); proteasome inhibition experiments; LDHA Y10 phosphorylation assay; in vitro and in vivo tumor growth/metastasis models\",\n      \"journal\": \"Signal transduction and targeted therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical and cellular assays identifying a specific binding interaction, PTM mechanism, and metabolic consequence with in vivo validation\",\n      \"pmids\": [\"35115484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Cytl1 expression in mouse endometrium increases significantly during embryo implantation, and Cytl1 enhances endometrial cell proliferation, stimulates secretion of LIF and HB-EGF, and enhances adhesion of endometrial cells to JAR spheroids, suggesting a role in embryo implantation.\",\n      \"method\": \"In vivo mouse expression profiling; cell proliferation assays; ELISA for LIF and HB-EGF; cell-cell adhesion assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — multiple functional readouts but single lab, no receptor/pathway mechanism established\",\n      \"pmids\": [\"26800213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CYTL1 was identified as a secreted protein whose chondrogenic activity involves modulation of Sox9 and IGF-1 expression, and CCR2 has been identified as a likely receptor mediating the ERK signalling pathway; CYTL1 also appears to mediate TGF-beta-Smad signalling independently of CCR2.\",\n      \"method\": \"Review/synthesis of prior experimental data (not primary experimental data in this paper)\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — review article synthesizing prior findings; CCR2/ERK and TGF-beta/Smad pathway links not directly demonstrated in primary experiments within this paper\",\n      \"pmids\": [\"31089746\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CYTL1 (Cytokine-like 1/Protein C17) is a secreted cytokine-like protein that promotes chondrogenesis by stimulating Sox9 transcriptional activity and IGF-1 expression, maintains cartilage homeostasis (loss exacerbates osteoarthritis), inhibits tumor metastasis by reducing STAT3 phosphorylation, and in its intracellular signal-peptide-deleted form (ΔCYTL1) acts as a tumor suppressor by competitively binding NDUFV1 to block MDM2-mediated proteasomal degradation, thereby stabilizing NDUFV1, increasing NAD+ levels, and attenuating LDHA Y10 phosphorylation to suppress aerobic glycolysis in breast cancer.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CYTL1 is a secreted cytokine-like protein that functions as an autocrine/paracrine factor in chondrogenesis and cartilage homeostasis, and additionally acts as a tumor suppressor through both extracellular and intracellular mechanisms. As a secreted factor, CYTL1 promotes chondrogenic differentiation of mesenchymal cells by stimulating Sox9 transcriptional activity and inducing IGF-1 expression, and its genetic ablation in mice augments osteoarthritic cartilage destruction without affecting skeletal development [PMID:17644814, PMID:21652695]. Extracellular CYTL1 inhibits tumor metastasis and reduces STAT3 phosphorylation in cancer cells [PMID:31069137], while the intracellular signal-peptide-deleted form (ΔCYTL1) competitively binds NDUFV1 to block MDM2-mediated proteasomal degradation, stabilizing NDUFV1 and thereby increasing NAD⁺ levels and attenuating LDHA Y10 phosphorylation to suppress aerobic glycolysis in breast cancer [PMID:35115484]. Systemic CYTL1 expression also protects against inflammatory arthritis in vivo by reducing RANKL levels and blunting joint inflammation [PMID:21799806].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Establishing CYTL1 as a chondrogenic factor resolved its biological activity: it promotes mesenchymal chondrogenesis through Sox9 activation and IGF-1 induction, functioning as an autocrine differentiation signal rather than a classical immune cytokine.\",\n      \"evidence\": \"Exogenous recombinant CYTL1 and lentiviral overexpression in mouse limb bud mesenchymal micromass cultures with Sox9 activity assays and expression profiling\",\n      \"pmids\": [\"17644814\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The receptor mediating CYTL1's chondrogenic signal was not identified\",\n        \"Downstream signaling cascades beyond Sox9 and IGF-1 were not mapped\",\n        \"In vivo requirement for CYTL1 in skeletal development was untested\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic ablation revealed that CYTL1 is dispensable for cartilage development but essential for cartilage homeostasis under pathological stress, shifting the functional model from a developmental factor to a maintenance/protective factor.\",\n      \"evidence\": \"Cytl1 knockout mice subjected to destabilization of the medial meniscus OA model with histological analysis\",\n      \"pmids\": [\"21652695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The molecular mechanism by which CYTL1 protects against cartilage destruction was not defined\",\n        \"Whether CYTL1 signals through a specific receptor in chondrocytes in vivo was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Systemic CYTL1 overexpression demonstrated an anti-inflammatory and bone-protective role in arthritis, broadening its function beyond chondrogenesis to include suppression of RANKL and joint inflammation.\",\n      \"evidence\": \"In vivo systemic overexpression in collagen antibody-induced arthritis mouse model with histology, gene expression profiling, and RANKL measurement\",\n      \"pmids\": [\"21799806\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The direct cellular targets of CYTL1 in the inflammatory joint were not identified\",\n        \"The signaling pathway through which CYTL1 suppresses RANKL was not determined\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery of CYTL1 upregulation during embryo implantation and its ability to stimulate endometrial cell proliferation and adhesion extended its functional repertoire to reproductive biology.\",\n      \"evidence\": \"In vivo mouse endometrial expression profiling, cell proliferation assays, ELISA for LIF/HB-EGF, and JAR spheroid adhesion assays\",\n      \"pmids\": [\"26800213\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The receptor and signaling pathway mediating endometrial effects were not identified\",\n        \"Genetic loss-of-function in the implantation context was not tested\",\n        \"Whether CYTL1's endometrial role is required in vivo for fertility is unknown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that secreted CYTL1 inhibits tumor metastasis and reduces STAT3 phosphorylation established a tumor-suppressive extracellular signaling axis distinct from its chondrogenic function.\",\n      \"evidence\": \"Recombinant CYTL1 treatment and overexpression in lung and breast cancer cell lines; migration/invasion assays; Western blot for pSTAT3; experimental and spontaneous metastasis mouse models\",\n      \"pmids\": [\"31069137\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The receptor through which CYTL1 suppresses STAT3 in cancer cells was not identified\",\n        \"Whether STAT3 inhibition is direct or mediated through an intermediate kinase was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of the intracellular signal-peptide-deleted form (ΔCYTL1) as a competitive inhibitor of MDM2-mediated NDUFV1 degradation revealed a cell-autonomous tumor-suppressive mechanism that stabilizes NDUFV1, increases NAD⁺, and suppresses LDHA-driven aerobic glycolysis.\",\n      \"evidence\": \"Co-immunoprecipitation, competitive binding assays, site-directed ΔCYTL1 constructs, proteasome inhibition, LDHA Y10 phosphorylation assays, and in vivo tumor growth/metastasis models in breast cancer\",\n      \"pmids\": [\"35115484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The relative physiological abundance of the intracellular ΔCYTL1 form versus the secreted form in normal tissues is undefined\",\n        \"Whether ΔCYTL1 generation is regulated or constitutive is unknown\",\n        \"Independent replication of the NDUFV1 stabilization mechanism in other cancer types has not been reported\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the cell-surface receptor for secreted CYTL1 remains unresolved: CCR2 has been computationally proposed but not experimentally validated, and the signaling cascades linking receptor engagement to Sox9 activation, STAT3 suppression, and cartilage protection are not defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No receptor has been experimentally confirmed for secreted CYTL1\",\n        \"The relationship between extracellular and intracellular CYTL1 functions is mechanistically unconnected\",\n        \"Structural determination of CYTL1 protein has not been performed experimentally\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NDUFV1\",\n      \"MDM2\",\n      \"LDHA\",\n      \"SOX9\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}